Are the results of the SEAM-RA trial generalizable to other TNF inhibitors given the differences in immunogenicity?
Withdrawal of methotrexate may lead to more disease flares and lack of recoverability with other TNF inhibitors.
Answer from: at Academic Institution
This is a great question, and an important one because different TNF inhibitors have different immunogenicity and patients can make anti-drug antibodies that can effectively neutralize the drug and render it a less effective treatment option. This tends to happen more with some molecular constructs ...
Sign in or Register to read more